gb GENETIC A1AT
The kit is intended for detection of mutations PI*S and PI*Z in the alpha 1 antitrypsin gene in human genomic DNA. Detection is based on real-time polymerase chain reaction (qPCR) using fluorescently labelled probes (allelic discrimination).
Alpha-1-antitrypsin (A1AT) is one of the serine protease inhibitors (SERPIN) which serves as an inhibitor of neutrofile elastase in lungs. The mutations in the A1AT gene lead to changes in
the protein structure and loss of function. Alpha-1-antitrypsin deficiency is associated with lung diseases such as chronic obstructive pulmonary disease (COPD).
The main risk factors for COPD are smoking, dusty work or repeated respiratory infections. A1AT deficiency can cause liver disease (hepatitis, cirrhosis) in both, neonates and adults. The most frequent mutations which cause a deficiency in alpha-1-antitrypsin are PI*S and PI*Z. Mutation PI*S is caused by substitution of E264V and makes a gradual reduction in protein levels. Mutation PI*Z is caused by substitution of E342K and makes a significant A1AT level reduction in blood serum.
Parameters of the diagnostic kit
- ready-to-use assay
- sample concentration 1-100 ng/µl
- positive and negative controls included
- FAM and HEX channels detection
- identical amplification profile as gb HEMO, gb GENETIC, gb PHARM kits